Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 288

1.

EMERGING THERAPIES FOR EOSINOPHILIC ESOPHAGITIS.

Greuter T, Hirano I, Dellon ES.

J Allergy Clin Immunol. 2019 Nov 6. pii: S0091-6749(19)31474-5. doi: 10.1016/j.jaci.2019.10.027. [Epub ahead of print]

PMID:
31705907
2.

Esophageal eosinophilia accompanies food allergy to hen egg white protein in young pigs.

Plundrich NJ, Smith AR, Borst LB, Snider DB, Käser T, Dellon ES, Blikslager AT, Odle J, Lila MA, Laster SM.

Clin Exp Allergy. 2019 Nov 8. doi: 10.1111/cea.13527. [Epub ahead of print]

PMID:
31702085
3.

Mucosal Eosinophilia Is an Independent Predictor of Vedolizumab Efficacy in Inflammatory Bowel Diseases.

Kim EM, Randall C, Betancourt R, Keene S, Lilly A, Fowler M, Dellon ES, Herfarth HH.

Inflamm Bowel Dis. 2019 Oct 21. pii: izz251. doi: 10.1093/ibd/izz251. [Epub ahead of print]

PMID:
31633167
4.

Rare Co-occurrence of Eosinophilic Esophagitis and Type 2B von Willebrand Disease: Implications for Endoscopic Surveillance and Esophageal Dilation.

Corder SR, Weston BW, Dellon ES.

ACG Case Rep J. 2019 May 14;6(5):e00069. doi: 10.14309/crj.0000000000000069. eCollection 2019 May.

5.

Efficacy of Dupilumab in a Phase 2 Randomized Trial of Adults With Active Eosinophilic Esophagitis.

Hirano I, Dellon ES, Hamilton JD, Collins MH, Peterson K, Chehade M, Schoepfer AM, Safroneeva E, Rothenberg ME, Falk GW, Assouline-Dayan Y, Zhao Q, Chen Z, Swanson BN, Pirozzi G, Mannent L, Graham NMH, Akinlade B, Stahl N, Yancopoulos GD, Radin A.

Gastroenterology. 2019 Oct 5. pii: S0016-5085(19)41415-7. doi: 10.1053/j.gastro.2019.09.042. [Epub ahead of print]

6.

An Increasing Trend of Eosinophilic Esophagitis in Korea and the Clinical Implication of the Biomarkers to Determine Disease Activity and Treatment Response in Eosinophilic Esophagitis.

Kim GH, Park YS, Jung KW, Kim M, Na HK, Ahn JY, Lee JH, Kim DH, Choi KD, Song HJ, Lee GH, Dellon ES, Jung HY.

J Neurogastroenterol Motil. 2019 Oct 30;25(4):525-533. doi: 10.5056/jnm19066.

7.

Geospatial distribution and characteristics of eosinophilic gastrointestinal disorder clinics in the United States.

Rukasin CRF, Hemler JA, Dellon ES, Curry-Johnson S, Hiremath G.

Ann Allergy Asthma Immunol. 2019 Sep 27. pii: S1081-1206(19)31240-2. doi: 10.1016/j.anai.2019.09.019. [Epub ahead of print] No abstract available.

PMID:
31568856
8.

Persistent Basal Cell Hyperplasia Is Associated With Clinical and Endoscopic Findings in Patients With Histologically Inactive Eosinophilic Esophagitis.

Whelan KA, Godwin BC, Wilkins B, Elci OU, Benitez A, DeMarshall M, Sharma M, Gross J, Klein-Szanto AJ, Liacouras CA, Dellon ES, Spergel JM, Falk GW, Muir AB, Nakagawa H.

Clin Gastroenterol Hepatol. 2019 Sep 6. pii: S1542-3565(19)30977-2. doi: 10.1016/j.cgh.2019.08.055. [Epub ahead of print]

PMID:
31499251
9.

Rapid Recurrence of Eosinophilic Esophagitis Activity After Successful Treatment in the Observation Phase of a Randomized, Double-Blind, Double-Dummy Trial.

Dellon ES, Woosley JT, Arrington A, McGee SJ, Covington J, Moist SE, Gebhart JH, Galanko JA, Baron JA, Shaheen NJ.

Clin Gastroenterol Hepatol. 2019 Sep 6. pii: S1542-3565(19)30972-3. doi: 10.1016/j.cgh.2019.08.050. [Epub ahead of print]

PMID:
31499249
10.

Budesonide Oral Suspension Significantly Improves Eosinophilic Esophagitis Histology Scoring System Results: Analyses From a 12-Week, Phase 2, Randomized, Placebo-controlled Trial.

Collins MH, Dellon ES, Katzka DA, Hirano I, Williams J, Lan L.

Am J Surg Pathol. 2019 Nov;43(11):1501-1509. doi: 10.1097/PAS.0000000000001361.

PMID:
31498177
11.

Dietary Elimination Therapy Is Effective in Most Adults With Eosinophilic Esophagitis Responsive to Proton Pump Inhibitors.

Iglesia EGA, Reed CC, Nicolai E, Dellon ES.

Clin Gastroenterol Hepatol. 2019 Aug 10. pii: S1542-3565(19)30885-7. doi: 10.1016/j.cgh.2019.08.010. [Epub ahead of print] No abstract available.

PMID:
31408702
12.

How to Advance Research, Education, and Training in the Study of Rare Diseases.

Groft SC, Gopal-Srivastava R, Dellon ES, Gupta SK.

Gastroenterology. 2019 Oct;157(4):917-921. doi: 10.1053/j.gastro.2019.08.010. Epub 2019 Aug 8. No abstract available.

PMID:
31401141
13.

Pharmacotherapies for the Treatment of Eosinophilic Esophagitis: State of the Art Review.

de Rooij WE, Dellon ES, Parker CE, Feagan BG, Jairath V, Ma C, Bredenoord AJ.

Drugs. 2019 Sep;79(13):1419-1434. doi: 10.1007/s40265-019-01173-2. Review.

PMID:
31352605
14.

Heartburn and dyspepsia symptom severity improves after treatment and correlates with histology in adults with eosinophilic esophagitis.

Eluri S, Perjar I, Betancourt R, Randall C, Raja S, Woosley JT, Shaheen NJ, Dellon ES.

Dis Esophagus. 2019 Apr 25. pii: doz028. doi: 10.1093/dote/doz028. [Epub ahead of print]

PMID:
31329864
15.

Heterogeneous antiretroviral drug distribution and HIV/SHIV detection in the gut of three species.

Thompson CG, Rosen EP, Prince HMA, White N, Sykes C, de la Cruz G, Mathews M, Deleage C, Estes JD, Charlins P, Mulder LR, Kovarova M, Adamson L, Arora S, Dellon ES, Peery AF, Shaheen NJ, Gay C, Muddiman DC, Akkina R, Garcia JV, Luciw P, Kashuba ADM.

Sci Transl Med. 2019 Jul 3;11(499). pii: eaap8758. doi: 10.1126/scitranslmed.aap8758.

PMID:
31270274
16.

Patients Value Symptoms and Quality of Life in Treating Eosinophilic Esophagitis: Not a Hard Truth to Swallow.

Chang JW, Dellon ES.

Gastroenterology. 2019 Aug;157(2):575-576. doi: 10.1053/j.gastro.2019.06.011. Epub 2019 Jun 13. No abstract available.

PMID:
31251893
17.

Increased Prevalence of Esophageal Eosinophilia in Patients with Inflammatory Bowel Disease.

Fan YC, Steele D, Kochar B, Arsene D, Long MD, Dellon ES.

Inflamm Intest Dis. 2019 Apr;3(4):180-186. doi: 10.1159/000497236. Epub 2019 Mar 20.

18.

Prevalence and Incidence of Intestinal Metaplasia and Dysplasia of Gastric Cardia in Patients With Barrett's Esophagus After Endoscopic Therapy.

Eluri S, Earasi AG, Moist SE, Dellon ES, Shaheen NJ.

Clin Gastroenterol Hepatol. 2019 May 8. pii: S1542-3565(19)30497-5. doi: 10.1016/j.cgh.2019.04.065. [Epub ahead of print]

PMID:
31077822
19.

Editorial: the evolving epidemiology of EoE-up, up, and away?

Dellon ES.

Aliment Pharmacol Ther. 2019 Jun;49(11):1448-1449. doi: 10.1111/apt.15252. No abstract available.

PMID:
31074899
20.

Propensity score methods to control for confounding in observational cohort studies: a statistical primer and application to endoscopy research.

Yang JY, Webster-Clark M, Lund JL, Sandler RS, Dellon ES, Stürmer T.

Gastrointest Endosc. 2019 Sep;90(3):360-369. doi: 10.1016/j.gie.2019.04.236. Epub 2019 Apr 30. Review.

PMID:
31051156
21.

Noninvasively Predicting Hemodynamic Response to Carvedilol in Cirrhotic Patients With Varices: You Have Some Ex-Spleening to Do.

Kim HP, Moon AM, Dellon ES.

Gastroenterology. 2019 Jun;156(8):2347-2349. doi: 10.1053/j.gastro.2019.04.028. Epub 2019 Apr 26. No abstract available.

PMID:
31034832
22.

Cost-effective care in eosinophilic esophagitis.

Dellon ES.

Ann Allergy Asthma Immunol. 2019 Aug;123(2):166-172. doi: 10.1016/j.anai.2019.04.010. Epub 2019 Apr 19. Review.

PMID:
31009702
23.

Increasing Rates of Diagnosis, Substantial Co-Occurrence, and Variable Treatment Patterns of Eosinophilic Gastritis, Gastroenteritis, and Colitis Based on 10-Year Data Across a Multicenter Consortium.

Pesek RD, Reed CC, Muir AB, Fulkerson PC, Menard-Katcher C, Falk GW, Kuhl J, Martin EK, Magier AZ, Ahmed F, Demarshall M, Gupta A, Gross J, Ashorobi T, Carpenter CL, Krischer JP, Gonsalves N, Spergel JM, Gupta SK, Furuta GT, Rothenberg ME, Dellon ES; Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR).

Am J Gastroenterol. 2019 Jun;114(6):984-994. doi: 10.14309/ajg.0000000000000228.

PMID:
31008735
24.

Decreased tenofovir diphosphate concentrations in a transgender female cohort: Implications for HIV pre-exposure prophylaxis (PrEP).

Cottrell ML, Prince HMA, Schauer AP, Sykes C, Maffuid K, Poliseno A, Chun TW, Huiting E, Stanczyk FZ, Peery AF, Dellon ES, Adams JL, Gay C, Kashuba ADM.

Clin Infect Dis. 2019 Apr 9. pii: ciz290. doi: 10.1093/cid/ciz290. [Epub ahead of print]

PMID:
30963179
25.

Illuminating Elimination Diets: Controversies Regarding Dietary Treatment of Eosinophilic Esophagitis.

Cotton CC, Durban R, Dellon ES.

Dig Dis Sci. 2019 Jun;64(6):1401-1408. doi: 10.1007/s10620-019-05602-w. Review.

PMID:
30927211
26.

Overestimation of the diagnosis of eosinophilic colitis with reliance on billing codes.

Muir AB, Jensen ET, Wechsler JB, Menard-Katcher P, Falk GW, Aceves SS, Furuta GT, Dellon ES, Rothenberg ME, Spergel JM.

J Allergy Clin Immunol Pract. 2019 Sep - Oct;7(7):2434-2436. doi: 10.1016/j.jaip.2019.03.020. Epub 2019 Mar 25. No abstract available.

PMID:
30922989
27.

Combination Therapy With Elimination Diet and Corticosteroids Is Effective for Adults With Eosinophilic Esophagitis.

Reed CC, Tappata M, Eluri S, Shaheen NJ, Dellon ES.

Clin Gastroenterol Hepatol. 2019 Mar 15. pii: S1542-3565(19)30273-3. doi: 10.1016/j.cgh.2019.03.009. [Epub ahead of print]

PMID:
30885887
28.

Efficacy of Budesonide vs Fluticasone for Initial Treatment of Eosinophilic Esophagitis in a Randomized Controlled Trial.

Dellon ES, Woosley JT, Arrington A, McGee SJ, Covington J, Moist SE, Gebhart JH, Tylicki AE, Shoyoye SO, Martin CF, Galanko JA, Baron JA, Shaheen NJ.

Gastroenterology. 2019 Jul;157(1):65-73.e5. doi: 10.1053/j.gastro.2019.03.014. Epub 2019 Mar 11.

PMID:
30872104
29.

Increased prevalence of autonomic dysfunction due to postural orthostatic tachycardia syndrome in patients with eosinophilic gastrointestinal disorders.

Huang KZ, Dellon ES.

J Gastrointestin Liver Dis. 2019 Mar;28(1):47-51. doi: 10.15403/jgld.2014.1121.281.syd.

30.

Subcutaneous immunotherapy in patients with eosinophilic esophagitis.

Robey BS, Eluri S, Reed CC, Jerath MR, Hernandez ML, Commins SP, Dellon ES.

Ann Allergy Asthma Immunol. 2019 May;122(5):532-533.e3. doi: 10.1016/j.anai.2019.02.022. Epub 2019 Mar 2. No abstract available.

PMID:
30831258
31.

A New Approach to Hemostasis in Acute Variceal Bleeding: Oh Spray Can You See?

Lieber SR, Dellon ES.

Gastroenterology. 2019 Mar;156(4):1211-1213. doi: 10.1053/j.gastro.2019.02.018. Epub 2019 Feb 16. No abstract available.

PMID:
30779924
32.

A Conceptual Approach to Understanding Treatment Response in Eosinophilic Esophagitis.

Dellon ES, Gupta SK.

Clin Gastroenterol Hepatol. 2019 Oct;17(11):2149-2160. doi: 10.1016/j.cgh.2019.01.030. Epub 2019 Jan 30. Review.

PMID:
30710696
33.

New IgE immediate hypersensitivity reactions on reintroduction of food restricted for treatment of eosinophilic esophagitis.

Gottlieb SJ, Markowitz JE, Dellon ES.

Ann Allergy Asthma Immunol. 2019 Apr;122(4):419-420. doi: 10.1016/j.anai.2019.01.010. Epub 2019 Jan 24. No abstract available.

PMID:
30684739
34.

No Maintenance, No Gain in Long-term Treatment of Eosinophilic Esophagitis.

Dellon ES.

Clin Gastroenterol Hepatol. 2019 Feb;17(3):397-399. doi: 10.1016/j.cgh.2018.07.038. No abstract available.

PMID:
30678839
35.

Seasonal exacerbation of eosinophilic esophagitis histologic activity in adults and children implicates role of aeroallergens.

Reed CC, Iglesia EGA, Commins SP, Dellon ES.

Ann Allergy Asthma Immunol. 2019 Mar;122(3):296-301. doi: 10.1016/j.anai.2018.12.013. Epub 2018 Dec 19.

PMID:
30578860
36.

Clinical Features at Baseline Cannot Predict Symptom Response to Placebo in Patients With Eosinophilic Esophagitis.

Hirano I, Dellon ES, Collins MH, Williams J, Lan L, Katzka DA.

Clin Gastroenterol Hepatol. 2019 Sep;17(10):2126-2128.e1. doi: 10.1016/j.cgh.2018.11.045. Epub 2018 Nov 28.

37.

Variation in Endoscopic Activity Assessment and Endoscopy Score Validation in Adults With Eosinophilic Esophagitis.

Schoepfer AM, Hirano I, Coslovsky M, Roumet MC, Zwahlen M, Kuehni CE, Hafner D, Alexander JA, Dellon ES, Gonsalves N, Leung J, Bussmann C, Collins MH, Newbury RO, Smyrk TC, Woosley JT, Yang GY, Romero Y, Katzka DA, Furuta GT, Gupta SK, Aceves SS, Chehade M, Spergel JM, Falk GW, Meltzer BA, Comer GM, Straumann A, Safroneeva E; International EEsAI Study Group.

Clin Gastroenterol Hepatol. 2019 Jul;17(8):1477-1488.e10. doi: 10.1016/j.cgh.2018.11.032. Epub 2018 Nov 23.

PMID:
30476587
38.

Eosinophilic Esophagitis.

Reed CC, Dellon ES.

Med Clin North Am. 2019 Jan;103(1):29-42. doi: 10.1016/j.mcna.2018.08.009. Epub 2018 Nov 1. Review.

PMID:
30466674
39.

Consortium of Eosinophilic Gastrointestinal Disease Researchers: Advancing the Field of Eosinophilic GI Disorders Through Collaboration.

Gupta SK, Falk GW, Aceves SS, Chehade M, Collins MH, Dellon ES, Gonsalves N, Hirano I, Mukkuda VA, Peterson KA, Spergel J, Yang GY, Furuta GT, Rothenberg ME; Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR).

Gastroenterology. 2019 Mar;156(4):838-842. doi: 10.1053/j.gastro.2018.10.057. Epub 2018 Nov 17. No abstract available.

PMID:
30452923
40.

RPC4046, a Monoclonal Antibody Against IL13, Reduces Histologic and Endoscopic Activity in Patients With Eosinophilic Esophagitis.

Hirano I, Collins MH, Assouline-Dayan Y, Evans L, Gupta S, Schoepfer AM, Straumann A, Safroneeva E, Grimm M, Smith H, Tompkins CA, Woo A, Peach R, Frohna P, Gujrathi S, Penenberg DN, Li C, Opiteck GJ, Olson A, Aranda R, Rothenberg ME, Dellon ES; HEROES Study Group.

Gastroenterology. 2019 Feb;156(3):592-603.e10. doi: 10.1053/j.gastro.2018.10.051. Epub 2018 Nov 2.

41.

Authors' response.

Spergel JM, Dellon ES, Liacouras CA, Hirano I, Molina-Infante J, Bredenoord AJ, Furuta GT.

Ann Allergy Asthma Immunol. 2018 Dec;121(6):747-748. doi: 10.1016/j.anai.2018.10.015. Epub 2018 Oct 13. No abstract available.

PMID:
30326321
42.

Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2018.

Peery AF, Crockett SD, Murphy CC, Lund JL, Dellon ES, Williams JL, Jensen ET, Shaheen NJ, Barritt AS, Lieber SR, Kochar B, Barnes EL, Fan YC, Pate V, Galanko J, Baron TH, Sandler RS.

Gastroenterology. 2019 Jan;156(1):254-272.e11. doi: 10.1053/j.gastro.2018.08.063. Epub 2018 Oct 10. Review. Erratum in: Gastroenterology. 2019 May;156(6):1936.

PMID:
30315778
43.

Eosinophilic Esophagitis and Epithelial Inflammation: Just the Tip of the Iceberg?

Venkatesh RD, Dellon ES.

Gastroenterology. 2018 Nov;155(5):1642-1644. doi: 10.1053/j.gastro.2018.10.016. Epub 2018 Oct 8. No abstract available.

PMID:
30308194
44.

Letter: screening for adrenal suppression in paediatric inflammatory bowel disease - authors' reply.

Philpott H, Dougherty MK, Dellon ES.

Aliment Pharmacol Ther. 2018 Oct;48(8):885-886. doi: 10.1111/apt.14954. No abstract available.

PMID:
30281837
45.

Clinical and Molecular Factors Associated With Histologic Response to Topical Steroid Treatment in Patients With Eosinophilic Esophagitis.

Eluri S, Selitsky SR, Perjar I, Hollyfield J, Betancourt R, Randall C, Rusin S, Woosley JT, Shaheen NJ, Dellon ES.

Clin Gastroenterol Hepatol. 2019 May;17(6):1081-1088.e2. doi: 10.1016/j.cgh.2018.09.005. Epub 2018 Sep 10.

PMID:
30213583
46.

Eosinophilic Esophagitis and the Eosinophilic Gastrointestinal Diseases: Approach to Diagnosis and Management.

Steinbach EC, Hernandez M, Dellon ES.

J Allergy Clin Immunol Pract. 2018 Sep - Oct;6(5):1483-1495. doi: 10.1016/j.jaip.2018.06.012. Epub 2018 Jul 3.

47.

An Evolving Approach to the Diagnosis of Eosinophilic Esophagitis.

Kim HP, Dellon ES.

Gastroenterol Hepatol (N Y). 2018 Jun;14(6):358-366.

48.

Safety and Acceptability of Esophageal Cytosponge Cell Collection Device in a Pooled Analysis of Data From Individual Patients.

Januszewicz W, Tan WK, Lehovsky K, Debiram-Beecham I, Nuckcheddy T, Moist S, Kadri S, di Pietro M, Boussioutas A, Shaheen NJ, Katzka DA, Dellon ES, Fitzgerald RC; BEST1 and BEST2 study investigators.

Clin Gastroenterol Hepatol. 2019 Mar;17(4):647-656.e1. doi: 10.1016/j.cgh.2018.07.043. Epub 2018 Aug 9.

49.

Longitudinal Growth Outcomes Following First-line Treatment for Pediatric Patients With Eosinophilic Esophagitis.

Jensen ET, Huang KZ, Chen HX, Landes LE, McConnell KA, Almond MA, Safta AM, Johnston DT, Durban R, Jobe L, Frost C, Donnelly S, Antonio B, Quiros A, Markowitz JE, Dellon ES.

J Pediatr Gastroenterol Nutr. 2019 Jan;68(1):50-55. doi: 10.1097/MPG.0000000000002114.

PMID:
30074576
50.

Summary of the updated international consensus diagnostic criteria for eosinophilic esophagitis: AGREE conference.

Spergel JM, Dellon ES, Liacouras CA, Hirano I, Molina-Infante J, Bredenoord AJ, Furuta GT; participants of AGREE.

Ann Allergy Asthma Immunol. 2018 Sep;121(3):281-284. doi: 10.1016/j.anai.2018.05.035. Epub 2018 Jul 18. No abstract available.

Supplemental Content

Loading ...
Support Center